Adolescent Medicine

Alcohol Abuse

Allergies and Infant Formula

Allergy, Immunology, and ENT

Animal Allergies

Autism

COVID-19

Cardiovascular Diseases

Cardiology

Atopic Dermatitis

Acne

Dermatology

Developmental/Behavioral Disorders

Drug Pipeline News

Emergency Medicine

Diabetes

Diabetes Type 2

Endocrinology

Gastroenterology

Gynecology

Antibiotic Resistance

Vaccination and Immunization

Bacterial Conjunctivitis

Vaccines

Infectious disease

Influenza

Anxiety

Depression

Mental Health

Concussion

Epilepsy

Headache

Neurology

Food Allergies

Obesity

Childhood Obesity

Nutrition

Nutrition News

Neonatal/Perinatology

Obstetrics-Gynecology & Women's Health

Oncology

Pain

Pharmacology

Practice Improvement

ADHD

Antisocial Personality Disorder

Psychiatry

Asthma

Cystic Fibrosis

Pediatric Asthma

Pneumonia

Respiratory

Rheumatoid Arthritis

Sexually Transmitted Diseases

Sexual Health

Skin Diseases

Telemedicine

News 

All News

PNP Corner

AAP Guidelines

Media

Around the Practice

Cure Connections

Expert Interviews

Insights

Medical World News

Peer Exchange

Peers & Perspectives

Podcasts

Webinars

Puzzler

Publications

Contemporary Pediatrics Journal

Supplements And Featured Publications

CME/CE

Resources

Handouts

Job Board

Conferences

Conference Coverage

Conference Listing

Partnerships

Subscribe

Print Subscription

eNewsletter

Editorial

Editorial Advisory Board

Writer’s Guidelines

Reference Guidelines

Meet the Editors

Joshua Fitch is an editor for Contemporary Pediatrics. 

Articles

Fitness benefits of additional after-school physical activity were observed for school children in China compared to choice of activity, while academic performance was not compromised according to a recently published study in JAMA Pediatrics. 

Academic performance not compromised with additional extracurricular activities in elementary school students

In this Contemporary Pediatrics® interview, Rupa Wong, MD, discusses the recent FDA approval of phentolamine ophthalmic solution 0.75% eye drops to treat pharmacologically-induced mydriasis, and how this could impact the treatment landscape for the pediatric population. [Editor's note: RYZUMVI was previously known as Nyxol, which is referenced in the interview.]



Will FDA approved phentolamine ophthalmic solution 0.75% eye drops impact pediatric care?

Results from the phase 3 MIRA-4 pediatric trial demonstrated a favorable safety and tolerability profile with no reported adverse events. Rupa Wong, MD, offers thoughts on the approval, and why it may not change day-to-day practice when it comes to the pediatric population.  

FDA approves phentolamine ophthalmic solution 0.75% eye drops for pharmacologically-induced mydriasis

In collaboration with Contemporary Pediatrics, Contemporary OB/GYN, and Contagion, Tina Tan, MD, FAAP, FIDSA, FPIDS, discusses the benefits of having new tools to fight RSV in infants, potential vaccine hesitancy, and RSV trends currently being observed. 

Discussing the upcoming RSV season, new tools, and vaccine hesitancy

About Us

Advertise

Contact Us

Terms and Conditions

Privacy

Do Not Sell My Personal Information

Contemporary Pediatrics

Facebook

Twitter

LinkedIn

Instagram

Spotlight

2022 Best Tech

Changing Landscape in RSV Prevention

Food Insecurity and the Dangers of Infant Formula Dilution

Getting into the Roots of Childhood Atopic Dermatitis

Opt-Out Chlamydia Screening in Adolescent Care

The Role of the Healthcare Provider Community in Increasing Public Awareness of RSV in All Infants

Update in Pediatric COVID-19 Vaccines

Clinical

View More

1rem

Authors

A toddler has been covered with ringed plaques for two months resistant to topical antifungal creams.

Case: A toddler with asymptomatic lesions

David Scott Therrien

Articles